HEOR Staff Writer

NICE Approves Ruxolitinib Cream for Treating Vitiligo with Facial Involvement

SAHPRA GMP Compliance: Addressing Allegations Against Adcock Ingram’s C...

Merck Portfolio Optimization: Strategic Reorganization for Enhanced Commercia...

EMA Validation of ENHERTU Breast Cancer Treatment for Post-Neoadjuvant Therapy

Zorginstituut Nederland’s Lecanemab Health Insurance Rejection: Implica...

Revised MenACWY Vaccination Strategy for Adolescents in Germany